This document provides a 139-page report on global clinical trials for kidney cancer (renal cell cancer) in the second half of 2012. It includes data on the number and location of clinical trials, breakdown of trials by phase, status, subject recruitment, and leading sponsors. The report aims to give an overview of the clinical trial landscape and assess trends in research and development for treating kidney cancer worldwide.

1. Kidney Cancer (Renal Cell Cancer) Global Clinical Trials
Review, H2, 2012
Report Details:
Published:December 2012
No. of Pages: 139
Price: Single User License – US$2500
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical Trials
Review, H2, 2012" provides data on the Kidney Cancer (Renal Cell Cancer) clinical trial scenario.
This report provides elemental information and data relating to the clinical trials on Kidney Cancer
(Renal Cell Cancer). It includes an overview of the trial numbers and their recruitment status as
per the site of trial conduction across the globe. The databook offers a preliminary coverage of
disease clinical trials by their phase, trial status, prominence of the sponsors and also provides
briefing pertaining to the number of trials for the key drugs for treating Kidney Cancer (Renal Cell
Cancer). This report is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by GlobalData''s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America,
Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and
sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner

2. - Abridged view of the performance of the trials in terms of their status, recruitment, location,
sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get your copy of this report @
http://www.reportsnreports.com/reports/210604-kidney-cancer-renal-cell-cancer-global-clinical-trials-review-h2-
2012.html
Major points covered in Table of Contents of this report include
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Kidney Cancer (Renal Cell Cancer) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Kidney Cancer (Renal Cell Cancer) 25
Subjects Recruited Over a Period of Time 35
Prominent Sponsors 36
Top Companies Participating in Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials 38
Prominent Drug Comparison 40
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
Bayer AG 45
Clinical Trial Overview of Bayer AG 45

3. GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Bristol-Myers Squibb Company 51
Clinical Trial Overview of Bristol-Myers Squibb Company 51
Eli Lilly and Company 52
Clinical Trial Overview of Eli Lilly and Company 52
Amgen Inc. 53
Clinical Trial Overview of Amgen Inc. 53
AVEO Pharmaceuticals, Inc. 54
Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 54
Argos Therapeutics, Inc. 55
Clinical Trial Overview of Argos Therapeutics, Inc. 55
Pierre Fabre Medicament 56
Clinical Trial Overview of Pierre Fabre Medicament 56
Abbott Laboratories 57
Clinical Trial Overview of Abbott Laboratories 57
AstraZeneca PLC 58
Clinical Trial Overview of AstraZeneca PLC 58
Agenus, Inc. 59
Clinical Trial Overview of Agenus, Inc. 59
Genentech, Inc. 60
Clinical Trial Overview of Genentech, Inc. 60
Seattle Genetics, Inc. 61
Clinical Trial Overview of Seattle Genetics, Inc. 61
Hoffmann-La Roche Inc. 62
Clinical Trial Overview of Hoffmann-La Roche Inc. 62
F. Hoffmann-La Roche Ltd. 63
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 63
Oxford BioMedica plc 64
Clinical Trial Overview of Oxford BioMedica plc 64
Celgene Corporation 65
Clinical Trial Overview of Celgene Corporation 65
Novartis Pharmaceuticals Corporation 66
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 66
Clinical Trial Overview of Top Universities / Institutes / Hospitals 67
Memorial Sloan Kettering Cancer Center 67
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67
The University of Texas M. D. Anderson Cancer Center 71
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 71
UCLA''s Jonsson Comprehensive Cancer Center 74

4. Clinical Trial Overview of UCLA''s Jonsson Comprehensive Cancer Center 74
Case Comprehensive Cancer Center 76
Clinical Trial Overview of Case Comprehensive Cancer Center 76
The University of Chicago 77
Clinical Trial Overview of The University of Chicago 77
Roswell Park Cancer Institute 78
Clinical Trial Overview of Roswell Park Cancer Institute 78
Beth Israel Deaconess Medical Center 79
Clinical Trial Overview of Beth Israel Deaconess Medical Center 79
Radboud University 80
Clinical Trial Overview of Radboud University 80
Barbara Ann Karmanos Cancer Institute 81
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 81
Wake Forest University 82
Clinical Trial Overview of Wake Forest University 82
Fred Hutchinson Cancer Research Center 83
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 83
Sarah Cannon Research Institute 84
Clinical Trial Overview of Sarah Cannon Research Institute 84
Mayo Clinic 85
Clinical Trial Overview of Mayo Clinic 85
Masonic Cancer Center 86
Clinical Trial Overview of Masonic Cancer Center 86
University Health Network 87
Clinical Trial Overview of University Health Network 87
Dana-Farber Cancer Institute 88
Clinical Trial Overview of Dana-Farber Cancer Institute 88
Fox Chase Cancer Center 89
Clinical Trial Overview of Fox Chase Cancer Center 89
Duke University 90
Clinical Trial Overview of Duke University 90
The Methodist Hospital System 91
Clinical Trial Overview of The Methodist Hospital System 91
University of California, San Francisco 92
Clinical Trial Overview of University of California, San Francisco 92
Five Key Clinical Profiles 93
Appendix 136
Abbreviations 136
Definitions 136
Research Methodology 137
Secondary Research 137
About GlobalData 138

5. Contact Us 138
Disclaimer 138
Source 139
List of Tables
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries,
2012* 10
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by
Top Countries, 2012* 11
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries,
2012* 12
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries,
2012* 13
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries,
2012* 14
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Five
Countries, 2012* 15
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, Top
Five Countries, 2012* 16
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries, 2012* 18
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by Trial
Status, 2012* 19
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries, 2012* 20
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by Trial
Status, 2012* 21
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase, 2012*
22
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by
Phase 2012* 23
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status,
2012* 24
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Suspended Clinical Trials, 2012*
25
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
26
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Terminated Clinical Trials, 2012*
28
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average Enrollment
Target Trends, 2006-2011 35
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37

6. Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies by
Phase, 2012* 39
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials by
Prominent Drugs, 2012* 40
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Pfizer Inc., 2012* 41
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Bayer AG, 2012* 45
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
GlaxoSmithKline plc, 2012* 47
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Novartis AG, 2012* 49
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Bristol-Myers Squibb Company, 2012* 51
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Eli Lilly and Company, 2012* 52
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Amgen Inc., 2012* 53
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
AVEO Pharmaceuticals, Inc., 2012* 54
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Argos Therapeutics, Inc., 2012* 55
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Pierre Fabre Medicament, 2012* 56
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Abbott Laboratories, 2012* 57
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
AstraZeneca PLC, 2012* 58
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Agenus, Inc., 2012* 59
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Genentech, Inc., 2012* 60
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Seattle Genetics, Inc., 2012* 61
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Hoffmann-La Roche Inc., 2012* 62
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
F. Hoffmann-La Roche Ltd., 2012* 63
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Oxford BioMedica plc, 2012* 64
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Celgene Corporation, 2012* 65

7. Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Novartis Pharmaceuticals Corporation, 2012* 66
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Memorial Sloan Kettering Cancer Center, 2012* 67
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
The University of Texas M. D. Anderson Cancer Center, 2012* 71
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
UCLA''s Jonsson Comprehensive Cancer Center, 2012* 74
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Case Comprehensive Cancer Center, 2012* 76
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
The University of Chicago, 2012* 77
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Roswell Park Cancer Institute, 2012* 78
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Beth Israel Deaconess Medical Center, 2012* 79
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Radboud University, 2012* 80
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Barbara Ann Karmanos Cancer Institute, 2012* 81
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Wake Forest University, 2012* 82
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Fred Hutchinson Cancer Research Center, 2012* 83
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Sarah Cannon Research Institute, 2012* 84
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Mayo Clinic, 2012* 85
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Masonic Cancer Center, 2012* 86
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
University Health Network, 2012* 87
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Dana-Farber Cancer Institute, 2012* 88
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Fox Chase Cancer Center, 2012* 89
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
Duke University, 2012* 90
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
The Methodist Hospital System, 2012* 91
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by
University of California, San Francisco, 2012* 92

8. List of Figures
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone (%),
2012* 9
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries,
2012* 10
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by
Top Countries, 2012* 11
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries
(%), 2012* 12
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%),
2012* 13
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries
(%), 2012* 14
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Five
Countries (%), 2012* 15
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, Top
Five Countries (%), 2012* 16
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by Trial
Status, 2012* 19
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by Trial
Status, 2012* 21
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase (%),
2012* 22
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by
Phase, 2012* 23
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status,
2012* 24
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average Enrollment
Target Trends, 2006-2011 35
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 36
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies by
Phase, 2012* 38
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials by
Prominent Drugs, 2012* 40
GlobalData Methodology 137
Contact: sales@reportsandreports.com for more information.